Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flamrase 25 EC tablets
1001010C0BKAAAD
|
Flamrase | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamrase 50 EC tablets
1001010C0BKABAE
|
Flamrase | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamrase 75mg SR tablets
1001010C0BKADAL
|
Flamrase | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Flamrase SR 100mg tablets
1001010C0BKACAF
|
Flamrase | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.